Pentostam, Liposomal and lipid complex preparations of Amphotericin B, or paromomycin can be given. In Brazil, Currently, the most common treatment for humans to cure Leishmaniasis is the drug pentavalent antimony. The treatment is expensive, toxic, and only “variably effective.” Although 80 percent of patients respond successfully to the drug, only 40 percent are successfully cured of the disease after one treatment. Most patients undergo multiple treatments that last 60 days each time.
Leishmania braziliensis
Leishmania major
Leishmania mexicana
Leishmania amazonensis
Leishmania donovani
Trypanosoma brucei
Trypanosoma evansi
Leishmania infantum